肌萎缩
医学
结直肠癌
内科学
肿瘤科
癌症
结肠疾病
梅德林
全身疗法
靶向治疗
作者
Julius Keyl,René Hosch,Fabian Hörst,Philipp Keyl,Amin Dada,J. Haubold,Jannis Straus,Jan Egger,Arndt Stahler,Annika Kurreck,Alexej Ballhausen,Sebastian Stintzing,Stefan Fruehauf,Lothar Müller,Annabel H. S. Alig,Tanja Trarbach,Sylvia Hartmann,Felix Nensa,Jens Kleesiek,Stefan Kasper
标识
DOI:10.1158/1078-0432.ccr-25-3080
摘要
The benefit of anti-EGFR therapy in mCRC is confined to patients with a high MBR. Automated sarcopenia assessment holds promise for personalized treatment intensification in mCRC.
科研通智能强力驱动
Strongly Powered by AbleSci AI